XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED BALANCE SHEETS - JPY (¥)
¥ in Millions
Sep. 30, 2017
Mar. 31, 2017
Cash and cash deposits:    
Cash and cash equivalents ¥ 2,667,593 ¥ 2,536,840
Time deposits 222,998 207,792
Deposits with stock exchanges and other segregated cash 250,597 227,456
Total cash and cash deposits 3,141,188 2,972,088
Loans and receivables:    
Loans receivable (including \537,664 million and \542,686 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 1,971,887 1,875,828
Receivables from customers (including \1,281 million and \19,703 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 210,637 148,378
Receivables from other than customers 996,012 1,076,773
Allowance for doubtful accounts (3,786) (3,551)
Total loans and receivables 3,174,750 3,097,428
Collateralized agreements:    
Securities purchased under agreements to resell (including \1,089,000 million and \1,111,277 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 12,751,325 11,456,591
Securities borrowed 5,827,070 7,273,234
Total collateralized agreements 18,578,395 18,729,825
Trading assets and private equity investments:    
Trading assets (including securities pledged as collateral of \5,123,444 million and \5,835,380 million as of March 31, 2017 and September 30, 2017, respectively; including \7,334 million and \6,152 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 16,354,297 15,165,310
Private equity investments (including \7,451 million and \7,085 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 19,085 27,054
Total trading assets and private equity investments 16,373,382 15,192,364
Other assets:    
Office buildings, land, equipment and facilities (net of accumulated depreciation and amortization of \445,000 million and \472,229 million as of March 31, 2017 and September 30, 2017, respectively) 335,189 349,696
Non-trading debt securities 726,993 775,025
Investments in equity securities 151,589 146,730
Investments in and advances to affiliated companies 397,872 420,116
Other (including \177,726 million and \186,630 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 1,226,342 1,168,806
Total other assets 2,837,985 2,860,373
Total assets 44,105,700 42,852,078
LIABILITIES AND EQUITY    
Short-term borrowings (including \401,300 million and \488,045 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 632,137 543,049
Payables and deposits:    
Payables to customers 1,144,583 1,005,670
Payables to other than customers 1,571,234 1,569,922
Deposits received at banks 1,210,816 1,132,843
Total payables and deposits 3,926,633 3,708,435
Collateralized financing:    
Securities sold under agreements to repurchase (including \390,677 million and \498,645 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 17,236,437 17,095,898
Securities loaned (including \149,377 million and \162,114 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 1,584,949 1,627,124
Other secured borrowings 378,474 338,069
Total collateralized financing 19,199,860 19,061,091
Trading liabilities 8,543,122 8,191,794
Other liabilities (including \11,202 million and \21,098 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 1,255,774 1,308,510
Long-term borrowings (including \2,562,962 million and \2,900,063 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 7,655,767 7,195,408
Total liabilities 41,213,293 40,008,287
Common stock    
No par value shares; Authorized-6,000,000,000 shares as of March 31, 2017 and September 30, 2017, Issued-3,822,562,601 shares as of March 31, 2017 and September 30, 2017, Outstanding-3,528,429,451 shares as of March 31, 2017 and 3,486,142,097 shares as of September 30, 2017 594,493 594,493
Additional paid-in capital 677,446 681,329
Retained earnings 1,736,867 1,663,234
Accumulated other comprehensive income 35,585 33,652
Total NHI shareholder's equity before treasury stock 3,044,391 2,972,708
Common stock held in treasury, at cost-294,133,150 shares as of March 31, 2017 and 336,420,504 shares as of September 30, 2017 (208,179) (182,792)
Total NHI shareholders' equity 2,836,212 2,789,916
Noncontrolling interests 56,195 53,875
Total equity 2,892,407 2,843,791
Total liabilities and equity 44,105,700 42,852,078
Variable Interest Entities [Member]    
Cash and cash deposits:    
Cash and cash equivalents 23,000 4,000
Total cash and cash deposits 23,000 4,000
Trading assets and private equity investments:    
Private equity investments (including \7,451 million and \7,085 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 2,000 2,000
Total trading assets and private equity investments 1,449,000 1,400,000
Other assets:    
Office buildings, land, equipment and facilities (net of accumulated depreciation and amortization of \445,000 million and \472,229 million as of March 31, 2017 and September 30, 2017, respectively) 8,000 15,000
Other (including \177,726 million and \186,630 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 50,000 44,000
Total other assets 58,000 59,000
Total assets 1,530,000 1,463,000
LIABILITIES AND EQUITY    
Short-term borrowings (including \401,300 million and \488,045 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 173,000 103,000
Collateralized financing:    
Trading liabilities 19,000 18,000
Other liabilities (including \11,202 million and \21,098 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 2,000 2,000
Long-term borrowings (including \2,562,962 million and \2,900,063 million measured at fair value by applying the fair value option as of March 31, 2017 and September 30, 2017, respectively) 891,000 851,000
Borrowings 1,064,000 954,000
Total liabilities ¥ 1,085,000 ¥ 974,000